Actively Recruiting
Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
Led by University of Alberta · Updated on 2026-03-16
20
Participants Needed
2
Research Sites
280 weeks
Total Duration
On this page
Sponsors
U
University of Alberta
Lead Sponsor
W
Women and Children's Health Research Institute, Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
CONDITIONS
Official Title
Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with type 1 diabetes for at least one year
- Post-menopausal for at least one year or had a hysterectomy with bilateral salpingo oophorectomy
- Able to perform aerobic and resistance exercise
- Able to visit the lab in Edmonton, Alberta (University of Alberta)
You will not qualify if you...
- HbA1c greater than 9.9%
- Frequent and unpredictable low blood sugar episodes
- Changed insulin management strategy within the last 2 months
- Blood pressure higher than 140/95
- Severe peripheral neuropathy
- History of heart disease
- Musculoskeletal injuries that affect exercise performance
- Use of medications other than insulin that affect glucose metabolism
- Body mass index over 30 kg/m2
- Smoking
- Moderate to high alcohol intake (more than 2 drinks per day)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Alberta Diabetes Institute
Edmonton, Alberta, Canada, T6G 2R3
Actively Recruiting
2
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2W 1R7
Actively Recruiting
Research Team
J
Jane E Yardley, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here